"Designing Growth Strategies is in our DNA"

Veterinary Oncology Market Size, Share & Industry Analysis, By Offering (Diagnostics {By Product [Instruments and Reagents & Consumables], By Technique [Cytology, Hematology, Clinical Biochemistry, and Others]} and Therapeutics {By Drug Class [Cytotoxic Chemotherapy Drugs, Targeted Anticancer Drugs, and Others], By Therapy Type [Targeted Therapy, Chemotherapy, Immunotherapy, and Others]}), By Cancer Type (Lymphoma, Mast Cell Tumor, Melanoma, Osteosarcoma, Mammary Tumors, and Others), By Animal Type (Canine, Feline, Equine, and Others), and Regional Forecast, 2026-2034

Last Updated: June 12, 2026 | Format: PDF | Report ID: FBI117236

 


To get information on various segments, share your queries with us

ATTRIBUTE DETAILS
Study Period 2021-2034
Base Year 2025
Estimated Year  2026
Forecast Period 2026-2034
Historical Period 2021-2024
Growth Rate CAGR of 10.70% from 2026-2034
Unit Value (USD Billion)
Segmentation By Offering, Cancer Type, Animal Type, and Region
By Offering
  • Diagnostics
    • By Product
      • Instruments
      • Reagents & Consumables
    • By Technique
      • Cytology
      • Histopathology / Anatomic Pathology
      • Hematology
      • Clinical Biochemistry
      • Immunodiagnostics
      • Molecular Diagnostics
      • Others
  • Therapeutics
    • By Drug Class
      • Cytotoxic Chemotherapy Drugs
      • Targeted Anticancer Drugs
      • Cancer Vaccines
      • Hormonal Drugs
      • Corticosteroids
      • Others
    • By Therapy Type
      • Targeted Therapy
      • Chemotherapy
      • Immunotherapy
      • Others
By Cancer Type
  • Lymphoma
  • Mast Cell Tumor
  • Melanoma
  • Osteosarcoma
  • Mammary Tumors
  • Soft Tissue Sarcoma
  • Hemangiosarcoma
  • Squamous Cell Carcinoma
  • Others
By  Animal Type
  • Canine
  • Feline
  • Equine
  • Others
By Region 
  • North America (By Offering, Cancer Type, Animal Type, and Country)
    • U.S. 
    • Canada
  • Europe (By Offering, Cancer Type, Animal Type, and Country/Sub-region)
    • Germany 
    • U.K.
    • France 
    • Spain 
    • Italy 
    • Scandinavia  
    • Rest of Europe
  • Asia Pacific (By Offering, Cancer Type, Animal Type, and Country/Sub-region)
    • China 
    • Japan 
    • India 
    • Australia 
    • Southeast Asia 
    • Rest of Asia Pacific 
  • Latin America (By Offering, Cancer Type, Animal Type, and Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Offering, Cancer Type, Animal Type, and Country/Sub-region)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

 

  • 2021-2034
  • 2025
  • 2021-2024
  • 214
Download Free Sample

    man icon
    Mail icon

Get 30-60 hrs Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann